Consumer preference for dinoprostone vaginal gel using stated preference discrete choice modelling

PharmacoEconomics

Volumn 21, Issue 10, 2003, Pages 721-735

  Taylor, Susan J ^a   Armour, Carol L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PROSTAGLANDIN E2;

ADOLESCENT; ADULT; ARTICLE; CESAREAN SECTION; CONSUMER; CONSUMER PREFERENCE; COST; EPIDURAL ANESTHESIA; FEMALE; HEALTH CARE POLICY; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; QUESTIONNAIRE;

ADOLESCENT; ADULT; AUSTRALIA; CHOICE BEHAVIOR; DINOPROSTONE; FEMALE; FINANCING, PERSONAL; GELS; HUMANS; LABOR, INDUCED; OXYTOCICS; PATIENT SATISFACTION; PREGNANCY; QUESTIONNAIRES; TIME FACTORS;

EID: 0042671099     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321100-00004     Document Type: Article

References (28)

1. Gafni A. Willingness to pay: what's in a name? Pharmacoeconomics 1998; 14 (5): 465-70
2. Johannesson M, Jonsson B. Economic evaluation in health care: is there a role for cost benefit analysis? Health Policy 1991; 17: 1-23
3. Donaldson C, Shackley P, Abdalla M. Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited. Health Econ 1997; 6: 145-59
4. Ryan M. A role for conjoint analysis in technology assessment in health care? Int J Technol Assess Health Care 1999; 15: 443-57
5. O'Brien BJ, Novosel S, Torrance G, et al. Assessing the economic value of a new antidepressant-a willingness to pay approach. Pharmacoeconomics 1995; 8: 34-45
6. O'Brien BJ, Goeree R, Gafni A, et al. Assessing the value of a new pharmaceutical: a feasibility study of contingent valuation in managed care. Med Care 1998; 36: 370-84
7. Zethraeus N. Willingness to pay for hormone replacement therapy. Health Econ 1998; 7: 31-8
8. Davey P, Grainger D, MacMillan J, et al. Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach. Pharmacoeconomics 1998; 13: 347-58
9. Taylor SJ, Armour CL. Measurement of consumer preference for treatments to induce labour: a willingness to pay approach. Health Expect 2000; 3: 203-16
10. Upjohn. Prostin E2 vaginal gel: as close to "natural" as labour induction can be. Sydney, Australia: Upjohn, 1991
11. Taylor SJ, Peat JK, Armour CL. An evaluation of Prostaglandin E2 vaginal gel use in practice. J Clin Pharm Ther 1999; 24: 303-10
12. Hahn GJ, Shapiro SS. A catalogue and computer programme for the design and analysis of orthogonal symmetric and asymmetric fractional factorial experiments. Schenectady (NY): General Electric Research and Development Center, 1964
13. Hair JFJ, Anderson RE, Tatham RL, et al. Multivariate data analysis with readings. 4th ed. New Jersey: Prentice Hall, 1995
14. McFadden D. Conditional logit analysis of qualitative choice behaviour. Berkley (CA): University of California, 1973
15. Greene WH. LIMDEP version 7, user's manual. Plainview (NY): Econometric Software Inc, 1998
16. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 1999; 48: 535-46
17. Domencich TA, McFadden D. Urban travel demand: a behavioral analysis. Amsterdam: North-Holland Publishing Company, 1975
18. Scott A. Giving things up to have more of others: the implications of limited suitability for eliciting preferences in health and health care [discussion paper 01/98]. Aberdeen: Health Economics Research Unit, University of Aberdeen, 1998
19. Ryan M, Hughes J. Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ 1997; 6: 261-73
20. Vick S, Scott A. Agency in health care: examining patients' preferences for attributes of the doctor-patient relationship. J Health Econ 1998; 17: 587-605
21. Bryan S, Buxton M, Sheldon R, et al. Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences. Health Econ 1998; 7: 595-603
22. Chinburapa V, Larson LN. Predicting prescribing intention and assessing drug attribute importance using conjoint analysis. J Pharm Mark Manage 1988; 3: 3-18
23. Ratcliffe J, Buxton M. Patients' preferences regarding the process and outcomes of life-saving technology. Int J Technol Assess Health Care 1999; 15: 340-51
24. Propper C. The disutility of time spent on the United Kingdom's National Health Service waiting lists. J Hum Resour 1995; 30: 677-700
25. McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost-benefit analysis in health care. Pharmacoeconomics 1999; 15 (4): 357-67
26. Dawes RM, Corrigan B. Linear models in decision making. Psychol Bull 1974; 81 (2): 95-106
27. Emery D, Barron F. Axiomatic and numerical conjoint measurement: an evaluation of diagnostic efficacy. Psychometrika 1979; 44: 195-210
28. Cramer JS. The logit model: an introduction for economists. New York: Edward Arnold, 1991